• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

诺氟沙星在实验动物中的药代动力学研究。

Pharmacokinetic studies of norfloxacin in laboratory animals.

作者信息

Gilfillan E C, Pelak B A, Bland J A, Malatesta P F, Gadebusch H H

出版信息

Chemotherapy. 1984;30(5):288-96. doi: 10.1159/000238283.

DOI:10.1159/000238283
PMID:6237890
Abstract

Pharmacokinetic studies were conducted with norfloxacin administered by the oral and subcutaneous routes to mice and rats, and by the oral route to rhesus monkeys. The compound was moderately well absorbed following oral dosing in these animal species. Serum levels in monkeys ranged from 1.0 to 2.35 micrograms/ml after an oral drug dose of 25 mg/kg of animal body weight and were similar to those in mice. Serum half-life of norfloxacin in rodents and monkeys was similar to that in humans. Concentrations of norfloxacin in tissues of mice, rats and monkeys were greater than those in serum suggesting a large volume of distribution for the drug.

摘要

对小鼠、大鼠进行了诺氟沙星经口服和皮下途径给药的药代动力学研究,并对恒河猴进行了经口服途径给药的药代动力学研究。在这些动物物种中,口服给药后该化合物吸收情况中等。给予动物体重25mg/kg的口服药物剂量后,猴子的血清水平在1.0至2.35微克/毫升之间,与小鼠的血清水平相似。诺氟沙星在啮齿动物和猴子体内的血清半衰期与人类相似。诺氟沙星在小鼠、大鼠和猴子组织中的浓度高于血清中的浓度,表明该药物的分布容积较大。

相似文献

1
Pharmacokinetic studies of norfloxacin in laboratory animals.诺氟沙星在实验动物中的药代动力学研究。
Chemotherapy. 1984;30(5):288-96. doi: 10.1159/000238283.
2
Absorption, distribution, metabolic fate, and elimination of pefloxacin mesylate in mice, rats, dogs, monkeys, and humans.甲磺酸培氟沙星在小鼠、大鼠、犬、猴及人体内的吸收、分布、代谢转归及消除
Antimicrob Agents Chemother. 1984 Apr;25(4):463-72. doi: 10.1128/AAC.25.4.463.
3
Pharmacokinetics of AT-2266 administered orally to mice, rats, dogs, and monkeys.AT-2266经口给予小鼠、大鼠、狗和猴后的药代动力学。
Antimicrob Agents Chemother. 1983 Jul;24(1):54-60. doi: 10.1128/AAC.24.1.54.
4
Toxicokinetic study of norfloxacin-induced arthropathy in juvenile animals.诺氟沙星诱发幼年动物关节病的毒代动力学研究。
Toxicol Appl Pharmacol. 1990 Sep 15;105(3):403-12. doi: 10.1016/0041-008x(90)90144-j.
5
Pharmacokinetic studies of CP-74,667, a new quinolone, in laboratory animals.新型喹诺酮类药物CP-74,667在实验动物中的药代动力学研究。
Antimicrob Agents Chemother. 1992 Aug;36(8):1671-6. doi: 10.1128/AAC.36.8.1671.
6
Pharmacokinetics of 4-acetylaminophenylacetic acid. 1st communication: absorption, distribution, metabolism and excretion in mice, rats, dogs and monkeys after single administration of 14C-labeled compound.4-乙酰氨基苯乙酸的药代动力学。首次通讯:单次给予14C标记化合物后在小鼠、大鼠、狗和猴体内的吸收、分布、代谢及排泄情况
Arzneimittelforschung. 1990 Jul;40(7):800-5.
7
Norfloxacin--a review of pharmacology and tissue penetration.诺氟沙星——药理学与组织穿透性综述
J Antimicrob Chemother. 1984 May;13 Suppl B:59-64. doi: 10.1093/jac/13.suppl_b.59.
8
Metabolic disposition and pharmacokinetics of pelrinone, a new cardiotonic drug, in laboratory animals and man.新型强心药培利酮在实验动物和人体中的代谢情况及药代动力学
Eur J Drug Metab Pharmacokinet. 1990 Jan-Mar;15(1):37-48. doi: 10.1007/BF03190126.
9
Studies on the metabolism and disposition of the new retinoid 4-[(5,6,7,8-tetrahydro-5,5,8,8-tetramethyl-2-naphthyl)carbamoyl] benzoic acid. 4th communication: absorption, metabolism, excretion and plasma protein binding in various animals and man.新型类视黄醇4-[(5,6,7,8-四氢-5,5,8,8-四甲基-2-萘基)氨基甲酰基]苯甲酸的代谢与处置研究。第四次通讯:在各种动物和人类中的吸收、代谢、排泄及血浆蛋白结合情况
Arzneimittelforschung. 1997 Mar;47(3):259-69.
10
Pipemidic acid: absorption, distribution, and excretion.吡哌酸:吸收、分布与排泄
Antimicrob Agents Chemother. 1975 Apr;7(4):441-6. doi: 10.1128/AAC.7.4.441.

引用本文的文献

1
Embryotoxic and teratogenic effects of norfloxacin in pregnant female albino rats.诺氟沙星对怀孕雌性白化大鼠的胚胎毒性和致畸作用。
Adv Pharmacol Sci. 2014;2014:924706. doi: 10.1155/2014/924706. Epub 2014 Feb 3.
2
Clinical pharmacokinetics of norfloxacin-glycine acetate after intravenous and oral administration in pigs.猪静脉注射和口服诺氟沙星-甘氨酸乙酸盐后的临床药代动力学
J Vet Sci. 2007 Dec;8(4):353-6. doi: 10.4142/jvs.2007.8.4.353.
3
In vitro and in vivo antibacterial activities of T-3761, a new quinolone derivative.新型喹诺酮衍生物T-3761的体外和体内抗菌活性
Antimicrob Agents Chemother. 1993 Mar;37(3):384-92. doi: 10.1128/AAC.37.3.384.
4
In vivo evaluation of A-56619 (difloxacin) and A-56620: new aryl-fluoroquinolones.A-56619(二氟沙星)和A-56620的体内评估:新型芳基氟喹诺酮类药物
Antimicrob Agents Chemother. 1986 Feb;29(2):201-8. doi: 10.1128/AAC.29.2.201.
5
Effect of oral ofloxacin on fecal bacteria in human volunteers.口服氧氟沙星对人体志愿者粪便细菌的影响。
Antimicrob Agents Chemother. 1987 Jan;31(1):124-5. doi: 10.1128/AAC.31.1.124.
6
The fluoroquinolones: pharmacology, clinical uses, and toxicities in humans.氟喹诺酮类药物:人体药理学、临床应用及毒性
Antimicrob Agents Chemother. 1985 Nov;28(5):716-21. doi: 10.1128/AAC.28.5.716.
7
A norfloxacin dose finding study for selective decontamination of the digestive tract in pigs.一项关于猪消化道选择性去污的诺氟沙星剂量探索性研究。
Epidemiol Infect. 1989 Feb;102(1):93-103. doi: 10.1017/s0950268800029721.
8
Pharmacokinetic studies of CP-74,667, a new quinolone, in laboratory animals.新型喹诺酮类药物CP-74,667在实验动物中的药代动力学研究。
Antimicrob Agents Chemother. 1992 Aug;36(8):1671-6. doi: 10.1128/AAC.36.8.1671.